Objectives: The aim of this study was to investigate the effect of a piriformis injection on neuropathic pain in patients with piriformis syndrome. Methods: Thirty patients with unilateral hip and/or leg pain, a positive FAIR test (increased H-reflex latency with Flexion, Adduction and Internal Rotation), and a trigger point at the piriformis muscle were enrolled in this prospective study. All of the patients exhibited neuropathic pain scored according to the Douleur Neuropathique 4 (DN4) of ≥4 for at least 6 months. All of the patients received 4 mL of lidocaine 2%+1 mL of betamethazone to the piriformis muscle under the guidance of ultrasound. The Numeric Rating Scale (NRS), DN4, and the painDETECT (PD) questionnaire were used for outcome assessment. Results: A statistically significant improvement was seen in all scores (p
Amaç: Piriformis sendromlu hastalarda uygulanan piriformis enjeksiyonunun hastalardaki nöropatik ağrı üzerine etkisini değerlendirmek. Gereç ve Yöntem: Tek taraflı kalça ve/veya bacak ağrısı olan, FAIR testi pozitif ve piriformis kasında palpasyonla tetik nokta saptanan 30 hasta çalışmaya dahil edildi. Bu prospektif çalışmada, tüm hastaların Douleur Neuropathique 4 (DN4) skoru en az 6 aydır 4 veya üzerinde idi. Tüm hastalara ultrason eşliğinde piriformis kasına 4 ml lidokain 2% + 1 ml betametazon enjekte edildi. Post-enjeksiyon 1. hafta ve 1. ayda hastalar değerlendirildi. Çalışmamızda, Numerik ağrı skalası (NAS), DN4, PainDETECT anketi (PDA) yöntemlerini kullandık. Bulgular: Başlangıç değerlerine göre 1. hafta ve 1. ay sonuçları karşılaştırıldığında tüm skorlarda istatistiksel olarak anlamlı düzelme olduğu görüldü (p
___
1. Yeoman WB. The relation of arthritis of the sacroiliac joint to sciatica: with an analysis of 100 cases. Lancet 1928;2:1119– 22.
2. G. Windisch, Braun EM, Anderhuber F. Piriformis muscle: clinical anatomy and consideration of the piriformis syndrome. Surg Radiol Anat 2007;29(1):37–45.
3. Beaton LE, Anson BJ. The relation of the sciatic nerve and of its subdivisions to the piriformis muscle. Anat Rec 1937;70(1):1–5.
4. Reus M, de Dios Berna J, Vazquez V, Redondo MV, Alonso J. Piriformis syndrome: a simple technique for US-guided infiltration of the perisciatic nerve. Preliminary results. Eur Radiol 2008;18(3):616–20.
5. Kirschner JS, Foye PM, Cole JL. Piriformis syndrome, diagnosis and treatment. Muscie Nerve 2009;40(1):10–8.
6. Huerto AP, Yeo SN, Ho KY. Piriformis muscle injection using ultrasonography and motor stimulation--report of a technique. Pain Physician 2007;10:687–90.
7. Chen CP, Shen CY, Lew HL. Ultrasound-guided injection of the piriformis muscle. Am J Phys Med Rehabil 2011;90(10):871–2.
8. Jeong HS, Lee GY, Lee EG, Joe EG, Lee JW, Kang HS. Longterm assessment of clinical outcomes of ultrasound-guided steroid injections in patients with piriformis syndrome. Ultrasonography 2015;34(3):206–10.
9. Misirlioglu TO, Akgun K, Palamar D, Erden MG, Erbilir T. Piriformis syndrome: comparison of the effectiveness of local anesthetic and corticosteroid injections: a doubleblinded, randomized controlled study. Pain Physician 2015;18(2):163–71.
10. Bouhassira D, Attal N, Alchaar H, Boureau F, Brochet B, Bruxelle J, et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 2005;114(1–2):29–36.
11. Unal-Cevik I, Sarioglu-Ay S, Evcik D. A comparison of the DN4 and LANSS questionnaires in the assessment of neuropathic pain: validity and reliability of the Turkish version of DN4. J Pain 2010;11(11):1129–35.
12. Freynhagen R, Baron R, Gockel U, Tölle TR. Pain DETECT: a new screening questionnaire to identify neuropathic ponents in patients with back pain. Curr Med Res Opin 2006;22(10):1911–20.
13. Alkan H, Ardic F, Erdoğan C, Sahin F, Sarsan A, Fındıkoğlu G. Turkish version of the painDETECT questionnaire in the assessment of neuropathic pain: a validity and reliability study. Pain Medicine 2013;14(12):1933–43.
14. Chen WS: Sciatica due to piriformis pyomyositis. Report of a case. J Bone Joint Surg 1992;74(10):1546–8.
15. Sayson SC, Ducey JP, Maybrey JB, Wesley RL, Vermilion D. Sciatic entrapment neuropathy associated with an anomalous piriformis muscle. Pain 1994;59(1):149–52.
16. Pecina M. Contribution to the etiological explanation of the piriformis syndrome. Acta Anat 1979;105(2):181–7.
17. Kleinman N, Patel AA, Benson C, Macario A, Kim M, Biondi DM. Economic Burden of Back and Neck Pain: Effect of a Neuropathic Component. Popul Health Manag 2014;17(4):224–32.
18. Haanpää M, Attal N, Backonja M, Baron R, Bennett M, Bouhassira D,et al. NeuPSIG guidelines on neuropathic pain assessment. Pain 2011;152(1):14–27.
19. Smith BH, Torrance N. Epidemiology of Neuropathic Pain and Its Impact on Quality of Life. Curr Pain Headache Rep 2012;16(3):191–8.
20. Gudala K, Ghai B, Bansal D. Usefulness of four commonly used neuropathic pain screening questionnaires in patients with chronic low back pain: a cross-sectional study. Korean J Pain 2017;30(1):51–8.
21. Jankovic D, Peng P, van Zundert A. Brief review: piriformis syndrome: etiology, diagnosis, and management. Can J Anaesth 2013;60(10):1003–12.
22. Ozisik, Pinar Akdemir, et al. “CT-guided piriformis muscle injection for the treatment of piriformis syndrome.” Turkish neurosurg 2014;24(4):471–7.
23. Cassidy L, Walters A, Bubb K, Shoja MM, Tubbs RS, Loukas M. Piriformis syndrome: implications of anatomical variations, diagnostic techniques, and treatment options. Surg Radiol Anat 2012;34(6):479–86.
24. Reus M, de Dios Berna J, Vazquez V, Redondo MV, Alonso J. Piriformis syndrome: a simple technique for US-guided infiltration of the perisciatic nerve. Preliminary results. Eur Radiol 2008;18(3):616–20.
25. Fishman LM, Konnoth C, Rozner B. Botulinum neurotoxin type B and physical therapy in the treatment of piriformis syndrome: A dose-finding study. Am J Phys Med Rehabil 2004;83(1):42–50.
26. Fishman LM, Anderson C, Rosner B. Botox and physical therapy in the treatment of piriformis syndrome. Am J Phys Med Rehabil 2002; 81(12):936–42.